Back

The Proportional Treatment Effect: A Metric That Empowers and Connects

WANG, G.; Liao, Y.; Li, C.; Jin, K.; Li, Y.; Cutter, G. R.

2025-02-13 neurology
10.1101/2025.02.12.25322182 medRxiv
Show abstract

Clinical trials with continuous endpoints, evaluate efficacy by comparing the difference in mean changes from baseline between groups. However, clinicians often interpret results in terms of a proportional reduction rather than an absolute difference. An alternative approach is to reparametrize this difference as a proportional treatment effect, calculated by dividing the difference by the placebo mean change. We demonstrate that, in theory, the proportional treatment effect can be more powerful than the simple difference in means while still controlling the type I error rate. This is achieved using the delta method as implemented in well-established computational tools like the R package msm and the SAS procedure NLMIXED. By analyzing data from phase III trials, we illustrate how a proportional treatment effect connects treatment outcomes across various endpoints and different presentation formats. The availability of these well-established statistical tools for estimating proportional treatment effects, combined with this theoretical demonstration, suggests an alternative test statistic for clinical trials with continuous endpoints.

Published in Journal of Biopharmaceutical Statistics · not in our set (fewer than 10 published preprints to learn from) · training set

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.